Combined with TGF-β (a Treg cytokine), our analysis for the Th1/Th2/Treg suggested that anti-inflammation and the regulation for cardiac immune microenvironment might be other possible mechanisms for the reversal of myocardial fibrosis by SMY. The gene discussed is TGFB1; the disease is Myocardial fibrosis.